<?xml version="1.0" encoding="UTF-8"?><xml><records><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>1</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Liu C.</style></author>,<author><style face="normal" font="default" size="100%">Chen Z.</style></author>,<author><style face="normal" font="default" size="100%">Li W.</style></author>,<author><style face="normal" font="default" size="100%">Huang L.</style></author>,<author><style face="normal" font="default" size="100%">Zhang Y.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Vitamin D enhances alveolar development in antenatal lipopolysaccharide-treated rats through the suppression of interferon-gamma production</style></title><secondary-title><style face="normal" font="default" size="100%">Frontiers in Immunology</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Bronchopulmonary dysplasia (BPD) is characterized by the premature arrest of alveolar development. Antenatal exposure to inflammation inhibits lung morphogenesis, thereby increasing the risk for the development of BPD. Here, we investigated whether vitamin D (VitD) enhances alveolar development in antenatal lipopolysaccharide (LPS)-treated rats, which is a model for BPD. We used an established animal model of BPD, and random assignment to the control group, LPS group, or LPS with VitD group. Levels of interferon (IFN)-gamma and interleukin-4 were detected by real-time polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay. IFN-gamma producing CD8+ T cells were assessed by flow cytometry, and the methylation status of the VitD-response element (VDRE) was analyzed by bisulfite sequencing PCR. 25-hydroxyvitamin D levels were measured by liquid chromatography tandem mass spectrometry in maternal serum samples collected from 86 pregnant women in a prospective birth cohort enrolled from 2012 to 2013. Our results showed that VitD effectively alleviated the simplification of the lung alveolar structure in BPD rats and suppressed LPS-induced IFN-gamma expression in the lung and spleen tissues. Further investigation revealed that VitD suppressed IFN-gamma production in CD8+ T cells. Specifically, VitD increased the methylation percentage of the VDRE in the IFN-gamma-promoter region and suppressed LPS-induced expression of IFN-gamma. Additionally, we observed an association between maternal VitD exposure during pregnancy and neonatal IFN-gamma levels in a prospective birth cohort, with a trend similar to that observed in the animal model. Our data suggested that supplementation of VitD could suppress IFN-gamma production, resulting in improved alveolar development in an LPS-induced BPD rat model.Copyright Â© 2018 Liu, Chen, Li, Huang and Zhang.</style></abstract><accession-num><style face="normal" font="default" size="100%">620086964</style></accession-num><auth-address><style face="normal" font="default" size="100%">L. Huang, Department of Neonatology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. E-mail: huanglisu@xinhuamed.com.cn</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.3389/fimmu.2017.01923</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">1664-3224</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><number><style face="normal" font="default" size="100%">JAN</style></number><volume><style face="normal" font="default" size="100%">8</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2018//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.frontiersin.org/articles/10.3389/fimmu.2017.01923/full</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed19&amp;NEWS=N&amp;AN=620086964</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">article</style></keyword>,<keyword><style face="normal" font="default" size="100%">bone marrow derived macrophage</style></keyword>,<keyword><style face="normal" font="default" size="100%">CD8+ T lymphocyte</style></keyword>,<keyword><style face="normal" font="default" size="100%">controlled study</style></keyword>,<keyword><style face="normal" font="default" size="100%">enzyme linked immunosorbent assay</style></keyword>,<keyword><style face="normal" font="default" size="100%">flow cytometry</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene control</style></keyword>,<keyword><style face="normal" font="default" size="100%">*interferon production</style></keyword>,<keyword><style face="normal" font="default" size="100%">liquid chromatography-mass spectrometry</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung development</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">male</style></keyword>,<keyword><style face="normal" font="default" size="100%">morphometry</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">rat</style></keyword>,<keyword><style face="normal" font="default" size="100%">real time polymerase chain reaction</style></keyword>,<keyword><style face="normal" font="default" size="100%">spleen tissue</style></keyword>,<keyword><style face="normal" font="default" size="100%">umbilical cord blood</style></keyword>,<keyword><style face="normal" font="default" size="100%">vitamin D responsive element</style></keyword>,<keyword><style face="normal" font="default" size="100%">25 hydroxyvitamin D/ec [Endogenous Compound]</style></keyword>,<keyword><style face="normal" font="default" size="100%">bisulfite</style></keyword>,<keyword><style face="normal" font="default" size="100%">*gamma interferon/ec [Endogenous Compound]</style></keyword>,<keyword><style face="normal" font="default" size="100%">interleukin 4/ec [Endogenous Compound]</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lipopolysaccharide</style></keyword>,<keyword><style face="normal" font="default" size="100%">*vitamin D</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>2</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lu T.</style></author>,<author><style face="normal" font="default" size="100%">Yang N.</style></author>,<author><style face="normal" font="default" size="100%">Ding B.-S.</style></author>,<author><style face="normal" font="default" size="100%">Dang S.</style></author>,<author><style face="normal" font="default" size="100%">Zhang W.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">A disintegrin and metalloproteinase with thrombospondin motifs 18 (ADAMTS18) is a novel regulator of BPD</style></title><secondary-title><style face="normal" font="default" size="100%">European Respiratory Journal</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Bronchopulmonary dysplasia (BPD) is seen commonly in preterm neonates. The pathogenesis of this condition remains poorly understood. ADAMTS18 is a member of ADAMTSs that has been implicated in development and various malignancies. Gene array analysis of a murine model of hyperoxic-induced BPD indicated that Admats18 is a novel gene associated with BPD, yet little is known about its actual functions in vivo. Here, we used an Adamts18 knockout (KO) mouse model to further investigate the role of ADAMTS18 in lung development and BPD progression. Adamts18 mRNA was expressed at different stages of lung development, particularly at the tips of growing bronchial branches of embryonic day (E) 14.5. Adamts18 KO mice exhibited occluded small airways, enlarged airspace, and significantly decreased radial alveolar count, leading to alveolar simplification with a reduction in the overall surface area for gas exchange. Aberrant elastin distribution and reduced pulmonary microvasculature were also seen in KO mice. Together, this first characterization of ADAMTS18 in BPD-like lung dysplasia provides new insight to diagnose or treat BPD clinically. (Figure presented).</style></abstract><accession-num><style face="normal" font="default" size="100%">626628967</style></accession-num><auth-address><style face="normal" font="default" size="100%">T. Lu, East China Normal University, Shanghai, China</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1183/13993003.congress-2018.PA4234</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">1399-3003</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><number><style face="normal" font="default" size="100%">Supplement 62
SP  -</style></number><volume><style face="normal" font="default" size="100%">52</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2018//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">https://erj.ersjournals.com/content/52/suppl_62/PA4234</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed19&amp;NEWS=N&amp;AN=626628967</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">airway</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">controlled study</style></keyword>,<keyword><style face="normal" font="default" size="100%">DNA microarray</style></keyword>,<keyword><style face="normal" font="default" size="100%">gas exchange</style></keyword>,<keyword><style face="normal" font="default" size="100%">in vivo study</style></keyword>,<keyword><style face="normal" font="default" size="100%">knockout mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung alveolus</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung development</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">malignant neoplasm</style></keyword>,<keyword><style face="normal" font="default" size="100%">microvasculature</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">murine model</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">prematurity</style></keyword>,<keyword><style face="normal" font="default" size="100%">protein expression</style></keyword>,<keyword><style face="normal" font="default" size="100%">protein function</style></keyword>,<keyword><style face="normal" font="default" size="100%">*ADAMTS protein</style></keyword>,<keyword><style face="normal" font="default" size="100%">*ADAMTS1 protein</style></keyword>,<keyword><style face="normal" font="default" size="100%">elastin</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">messenger RNA</style></keyword>,<keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>3</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Collins J.</style></author>,<author><style face="normal" font="default" size="100%">Lithopoulos M.</style></author>,<author><style face="normal" font="default" size="100%">Dos Santos C.</style></author>,<author><style face="normal" font="default" size="100%">Issa N.</style></author>,<author><style face="normal" font="default" size="100%">Moebius M.</style></author>,<author><style face="normal" font="default" size="100%">Ito C.</style></author>,<author><style face="normal" font="default" size="100%">Zhong S.</style></author>,<author><style face="normal" font="default" size="100%">Vadivel A.</style></author>,<author><style face="normal" font="default" size="100%">Thebaud B.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Impaired angiogenic supportive capacity and altered gene expression profile of CD146+ mesenchymal stromal cells isolated from hyperoxia-injured neonatal rat lungs</style></title><secondary-title><style face="normal" font="default" size="100%">European Respiratory Journal</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Background: Bronchopulmonary dysplasia (BPD), a common adverse outcome of extreme preterm birth, can be caused by oxygen-related lung injury and is characterized by arrested alveolar development. Mesenchymal stromal cells (MSCs) have lung protective effects. Conversely, BPD is associated with increased MSCs in tracheal aspirates. This apparent discrepancy is unexplored. We hypothesized that endogenous lung (L-)MSCs are perturbed in an oxygen-induced rat model mimicking BPD. Method(s): Rat pups were exposed to 21% or 95% O2 from postnatal day 0 to 10. On day 12, CD146+ L-MSCs were isolated and characterized. Epithelial and vascular repair potential were tested by scratch assay and endothelial network formation respectively, immune function by mixed lymphocyte reaction assay. Microarray analysis was performed using GSEA software. Result(s): L-MSCs isolated from hyperoxia rat pups had decreased CD73 expression and inhibited lung endothelial network formation. L-MSCs indiscriminately promoted epithelial wound healing and limited T-cell proliferation. Expression of anti-angiogenic genes of the axonal guidance cue pathway was increased after in vivo hyperoxia, whereas genes of the anti-inflammatory JAK/STAT and lung/vascular growth promoting FGF pathways were decreased. Conclusion(s): In vivo hyperoxia exposure alters the pro-angiogenic effects and FGF expression of L-MSCs. Additionally, decreased CD73 and JAK/STAT expression suggest decreased immune function. L-MSC function may be perturbed and contribute to BPD pathogenesis. These findings may lead to improvements in manufacturing exogenous MSCs with superior repair capabilities.</style></abstract><accession-num><style face="normal" font="default" size="100%">626627728</style></accession-num><auth-address><style face="normal" font="default" size="100%">J. Collins, Erasmus University Medical Centre, Rotterdam, Netherlands</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1183/13993003.congress-2018.LSC-1093</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">1399-3003</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><number><style face="normal" font="default" size="100%">Supplement 62
SP  -</style></number><volume><style face="normal" font="default" size="100%">52</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2018//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://erj.ersjournals.com/content/52/suppl_62/LSC-1093</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed19&amp;NEWS=N&amp;AN=626627728</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">angiogenesis</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">axon</style></keyword>,<keyword><style face="normal" font="default" size="100%">cell function</style></keyword>,<keyword><style face="normal" font="default" size="100%">cell proliferation</style></keyword>,<keyword><style face="normal" font="default" size="100%">controlled study</style></keyword>,<keyword><style face="normal" font="default" size="100%">drug toxicity</style></keyword>,<keyword><style face="normal" font="default" size="100%">endothelium</style></keyword>,<keyword><style face="normal" font="default" size="100%">*gene expression profiling</style></keyword>,<keyword><style face="normal" font="default" size="100%">*hyperoxia</style></keyword>,<keyword><style face="normal" font="default" size="100%">in vivo study</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung development</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung injury</style></keyword>,<keyword><style face="normal" font="default" size="100%">*mesenchymal stroma cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">microarray analysis</style></keyword>,<keyword><style face="normal" font="default" size="100%">mixed lymphocyte reaction</style></keyword>,<keyword><style face="normal" font="default" size="100%">newborn</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">prematurity</style></keyword>,<keyword><style face="normal" font="default" size="100%">protein expression</style></keyword>,<keyword><style face="normal" font="default" size="100%">protein function</style></keyword>,<keyword><style face="normal" font="default" size="100%">pup (rodent)</style></keyword>,<keyword><style face="normal" font="default" size="100%">rat</style></keyword>,<keyword><style face="normal" font="default" size="100%">rat model</style></keyword>,<keyword><style face="normal" font="default" size="100%">signal transduction</style></keyword>,<keyword><style face="normal" font="default" size="100%">software</style></keyword>,<keyword><style face="normal" font="default" size="100%">T lymphocyte</style></keyword>,<keyword><style face="normal" font="default" size="100%">vascular surgery</style></keyword>,<keyword><style face="normal" font="default" size="100%">wound healing assay</style></keyword>,<keyword><style face="normal" font="default" size="100%">5&apos; nucleotidase</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">fibroblast growth factor</style></keyword>,<keyword><style face="normal" font="default" size="100%">Janus kinase</style></keyword>,<keyword><style face="normal" font="default" size="100%">oxygen</style></keyword>,<keyword><style face="normal" font="default" size="100%">STAT protein</style></keyword>,<keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>4</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Minoo P.</style></author>,<author><style face="normal" font="default" size="100%">Li C.</style></author>,<author><style face="normal" font="default" size="100%">Ramanathan R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Genetic modeling of bronchopulmonary dysplasia identifies principal regulators of alveolar formation</style></title><secondary-title><style face="normal" font="default" size="100%">Neonatology</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Background: Since the first description of bronchopulmonary dysplasia (BPD) three decades ago, alveolar formation remains poorly understood. In contrast, there is detailed understanding of early lung development (branching morphogenesis). The relevance of the latter to BPD is uncertain. Objective(s): To identify the principal genetic regulators of alveogenesis, information that is necessary for preventing or treating BPD. Method(s): We devised a unique, cell-specific, genetic targeting of select signaling pathways including TGF-beta, PDGFA and IGF1 during postnatal alveolar formation in mice. Next generation RNA sequencing revealed conserved genes that are in common amongst the 3 models. The relevance of the mouse genetic studies was examined in human postmortem BPD lung samples. We inactivated the receptors for TGF-beta, or platelet-derived growth factor subunit A (PDGFA) or IGF1, in secondary crest myofibroblasts (SCMFs) which drive alveogenesis and generated 3 mouse models. Result(s): All mice developed respiratory distress shortly after birth. All mice also developed profound arrested alveolar formation (BPD phenocopy). The severity of the phenotype, added to SCMFs representing only 10-11.3% of total lung cells, is strong evidence for the robustness of these 3 central signaling pathways in alveolar formation. RNAseq and bio-informatics using sorted mutant and control SCMFs revealed a cluster of 117 genes in common amongst the 3 mutant lungs. Conclusion(s): Our innovative approach identified genes that participate in alveogenesis. These genes are dysregulated in human BPD lung samples. We show for the first time that one of the pathway&apos;s functions in alveolar formation parallels the function of antenatal steroid used as therapy to improve alveogenesis.</style></abstract><accession-num><style face="normal" font="default" size="100%">623056979</style></accession-num><auth-address><style face="normal" font="default" size="100%">P. Minoo, Division of Neonatology, Department of Pediatrics, LAC+USC Medical Center and Childrens Hospital Los Angeles, Los Angeles, CA, United States</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1159/000487833</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">1661-7819</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">113</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2018//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed19&amp;NEWS=N&amp;AN=623056979</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">animal cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal tissue</style></keyword>,<keyword><style face="normal" font="default" size="100%">bioinformatics</style></keyword>,<keyword><style face="normal" font="default" size="100%">controlled study</style></keyword>,<keyword><style face="normal" font="default" size="100%">drug therapy</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene mutation</style></keyword>,<keyword><style face="normal" font="default" size="100%">*genetic model</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung alveolus cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse model</style></keyword>,<keyword><style face="normal" font="default" size="100%">myofibroblast</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">phenotype</style></keyword>,<keyword><style face="normal" font="default" size="100%">respiratory distress</style></keyword>,<keyword><style face="normal" font="default" size="100%">RNA sequence</style></keyword>,<keyword><style face="normal" font="default" size="100%">signal transduction</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">platelet derived growth factor A</style></keyword>,<keyword><style face="normal" font="default" size="100%">somatomedin C</style></keyword>,<keyword><style face="normal" font="default" size="100%">steroid</style></keyword>,<keyword><style face="normal" font="default" size="100%">transforming growth factor beta</style></keyword>,<keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>5</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bik-Multanowski M.</style></author>,<author><style face="normal" font="default" size="100%">Revhaug C.</style></author>,<author><style face="normal" font="default" size="100%">Grabowska A.</style></author>,<author><style face="normal" font="default" size="100%">Dobosz A.</style></author>,<author><style face="normal" font="default" size="100%">Madetko-Talowska A.</style></author>,<author><style face="normal" font="default" size="100%">Zasada M.</style></author>,<author><style face="normal" font="default" size="100%">Saugstad O.D.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Hyperoxia-induced epigenetic silencing of TGF-beta pathway: Potential implications for pathogenesis of BPD</style></title><secondary-title><style face="normal" font="default" size="100%">Neonatology</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Introduction: Supplemental oxygen exposure is a risk factor for development of bronchopulmonary dysplasia (BPD). Reactive oxygen species may damage lung tissue, but hyperoxia has also a potential to alter the genome activity by means of altering DNA methylation. Understanding the epigenetic potential of hyperoxia can enable further improvement of therapeutic strategies in BPD. Objective(s): To identify hyperoxia-related alterations of DNA methylation, which could affect the activity of crucial genetic pathways involved in development of hyperoxia lung injury. Method(s): 24 newborn mice were randomized to hyperoxia (85% O2) or normoxia for 14 days continued with normoxia for the subsequent 14 days. The mice were killed on day 28 and lung tissue was analyzed with use of microarrays dedicated for assessment of genome methylation and expression profiles. Result(s): The mean DNA methylation level was higher in the hyperoxia in comparison with the normoxia group. The analysis of specific DNA fragments revealed hypermethylation of &gt; 1,300 gene promoters in the hyperoxia group confirming the presence of the DNA hypermethylation effects of hyperoxia. Further analysis showed significant enrichment of TGF-beta signaling pathway (p = 0.0013). The hypermethylated genes included Tgfbr1, Crebbp and Creb1, which play central roles in TGF-beta signaling pathway and in cell cycle regulation. The genome expression analysis revealed complementary upregulation of genes that are crucial for cell cycle regulation in the normoxia group (Crebbp, Smad2, Smad3). Conclusion(s): These results suggest involvement of methylation of TGF-beta pathway genes in lung tissue reaction to hyperoxia. The data indicate hyperoxia may be a programming factor in newborn mice.</style></abstract><accession-num><style face="normal" font="default" size="100%">623056874</style></accession-num><auth-address><style face="normal" font="default" size="100%">M. Bik-Multanowski, Department of Medical Genetics, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1159/000487833</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">1661-7819</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><number><style face="normal" font="default" size="100%">4</style></number><volume><style face="normal" font="default" size="100%">113</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2018//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed19&amp;NEWS=N&amp;AN=623056874</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal tissue</style></keyword>,<keyword><style face="normal" font="default" size="100%">cell cycle regulation</style></keyword>,<keyword><style face="normal" font="default" size="100%">controlled study</style></keyword>,<keyword><style face="normal" font="default" size="100%">DNA methylation</style></keyword>,<keyword><style face="normal" font="default" size="100%">*epigenetics</style></keyword>,<keyword><style face="normal" font="default" size="100%">female</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene expression</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene expression profiling</style></keyword>,<keyword><style face="normal" font="default" size="100%">*gene silencing</style></keyword>,<keyword><style face="normal" font="default" size="100%">*hyperoxia</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung injury</style></keyword>,<keyword><style face="normal" font="default" size="100%">male</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">newborn</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">promoter region</style></keyword>,<keyword><style face="normal" font="default" size="100%">protein expression</style></keyword>,<keyword><style face="normal" font="default" size="100%">protein function</style></keyword>,<keyword><style face="normal" font="default" size="100%">*signal transduction</style></keyword>,<keyword><style face="normal" font="default" size="100%">*TGF beta signaling</style></keyword>,<keyword><style face="normal" font="default" size="100%">upregulation</style></keyword>,<keyword><style face="normal" font="default" size="100%">cyclic AMP responsive element binding protein</style></keyword>,<keyword><style face="normal" font="default" size="100%">cyclic AMP responsive element binding protein binding protein</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">oxygen</style></keyword>,<keyword><style face="normal" font="default" size="100%">Smad2 protein</style></keyword>,<keyword><style face="normal" font="default" size="100%">Smad3 protein</style></keyword>,<keyword><style face="normal" font="default" size="100%">*transforming growth factor beta</style></keyword>,<keyword><style face="normal" font="default" size="100%">transforming growth factor beta receptor 1</style></keyword>,<keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>6</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Eldredge L.C.</style></author>,<author><style face="normal" font="default" size="100%">Creasy R.S.</style></author>,<author><style face="normal" font="default" size="100%">Lai J.</style></author>,<author><style face="normal" font="default" size="100%">Ziegler S.F.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Characterization of neonatal mononuclear phagocytes in hyperoxia-induced lung injury with novel roles for IL-1 family cytokines</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Respiratory and Critical Care Medicine</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Introduction Bronchopulmonary dysplasia (BPD) is a common and severe chronic lung disease of premature infants. Inflammation from oxygen exposure contributes to BPD pathogenesis. The naive newborn lung has a dominant type 2 immune response, including immunomodulatory macrophages. We previously found that depletion of CD11b-expressing monocyte/macrophages at birth led to severe acute hyperoxia-induced lung injury (HILI) with capillary leak and significant mortality. Analyses of CD11b-DTR+ and CD11c-DTR+, and CCR2-DTR+ depleted mice demonstrated protective roles for Ly6CloCD11chi interstitial macrophages/monocytes (IM) and alveolar macrophages (AM). In this study, we sought to explore the functions of specific mononuclear phagocyte populations in HILI as a model for BPD, focusing on role of IL-33 and other IL-1 cytokine family members. Methods HILI was used to model BPD in neonatal mice as previously described with FiO2 0.8-0.9. In parallel, C57BL/6 mice were exposed to 0.9 FiO2 or normoxia for 24h and we isolated four populations of mononuclear phagocytes - immature alveolar macrophages (AM), Ly6Chi IM, Ly6Clo IM, and dendritic cells (DC) - for RNASeq analysis. We then performed QPCR with nested primer sets targeting Type 2 inflammatory pathways in lungs from DT-treated CD11b-DTR+, CD11c-DTR+, and CCR2-DTR+ mice after 24h of hyperoxia. Results RNASeq analysis was performed on the four sorted mononuclear populations (AM, DC, Ly6Chi IM, and Ly6Clo IM) in normoxia and hyperoxia conditions at PN1. These populations were distinct based on principal component analysis (Figure 1). The IL-1 family member IL1f9 (IL-36g) was increased in hyperoxia-exposed mice by 9-fold in Ly6Clo IM, 7- fold in DC, and 4-fold in AM but not in Ly6Chi IM. Ly6Chi IM had upregulation of the M1 gene IL- 1a. Given our growing interest in the IL-1 family, we found that IL-33 expression in the newborn lung increases after 24h of hyperoxia. IL-33 expression is decreased in lungs of DT-treated CD11b-DTR+ mice compared with DTR-controls, but not in CD11c-DTR+ or CCR2-DTR+ mice. There was also a trend toward decreased levels of the downstream growth factor amphiregulin (Areg) in CD11b-DTR+ mice but not in CD11c-and CCR2-DTR+ mice. Another IL-1 family member IL-36g was increased in CD11b-DTR+ mice but unchanged in CD11c-and CCR2-DTR+ mice. Conclusions Mononuclear phagocyte sources of IL-1 family cytokines may play a protective role in HILI. This work furthers our understanding of how these innate cells modulate inflammatory lung injury in the neonatal lung. Future work will explore IL-33 and IL-36g in epithelial-innate cell interactions in HILI and BPD. $$graphic-3A22ACCC-77BF-44D3-ADE5- 28F08B16FD9C$$ (Figure presented) .</style></abstract><accession-num><style face="normal" font="default" size="100%">622967163</style></accession-num><auth-address><style face="normal" font="default" size="100%">L.C. Eldredge, Pediatric Pulmonology, Seattle Childrens Hospital, University of Washington, Seattle, WA, United States. E-mail: lauriech@uw.edu</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><isbn><style face="normal" font="default" size="100%">1535-4970</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><number><style face="normal" font="default" size="100%">MeetingAbstracts
SP  -</style></number><volume><style face="normal" font="default" size="100%">197</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2018//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A6113</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed19&amp;NEWS=N&amp;AN=622967163</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">animal cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">C57BL 6 mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">capillary leak syndrome</style></keyword>,<keyword><style face="normal" font="default" size="100%">cell interaction</style></keyword>,<keyword><style face="normal" font="default" size="100%">controlled study</style></keyword>,<keyword><style face="normal" font="default" size="100%">dendritic cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">drug toxicity</style></keyword>,<keyword><style face="normal" font="default" size="100%">female</style></keyword>,<keyword><style face="normal" font="default" size="100%">*hyperoxia-induced lung injury</style></keyword>,<keyword><style face="normal" font="default" size="100%">inflammation</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung alveolus macrophage</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">male</style></keyword>,<keyword><style face="normal" font="default" size="100%">monocyte</style></keyword>,<keyword><style face="normal" font="default" size="100%">mortality</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">newborn</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">principal component analysis</style></keyword>,<keyword><style face="normal" font="default" size="100%">protein expression</style></keyword>,<keyword><style face="normal" font="default" size="100%">*protein function</style></keyword>,<keyword><style face="normal" font="default" size="100%">real time polymerase chain reaction</style></keyword>,<keyword><style face="normal" font="default" size="100%">signal transduction</style></keyword>,<keyword><style face="normal" font="default" size="100%">upregulation</style></keyword>,<keyword><style face="normal" font="default" size="100%">amphiregulin</style></keyword>,<keyword><style face="normal" font="default" size="100%">CD11b antigen</style></keyword>,<keyword><style face="normal" font="default" size="100%">chemokine receptor CCR2</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">glycoprotein p 15095</style></keyword>,<keyword><style face="normal" font="default" size="100%">*interleukin 1</style></keyword>,<keyword><style face="normal" font="default" size="100%">interleukin 1alpha</style></keyword>,<keyword><style face="normal" font="default" size="100%">interleukin 33</style></keyword>,<keyword><style face="normal" font="default" size="100%">oxygen</style></keyword>,<keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>7</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lingappan K.</style></author>,<author><style face="normal" font="default" size="100%">Dong J.</style></author>,<author><style face="normal" font="default" size="100%">Coarfa C.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Role of alternative splicing in a murine model of neonatal hyperoxic lung injury and sex-biased differences: Implications for bronchopulmonary dysplasia</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Respiratory and Critical Care Medicine</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Background: BPD is characterized by impaired alveolarization and vascular growth. Male sex is considered an independent predictor for the development of BPD. The reasons underlying sexually dimorphic outcomes in premature neonates are not known. Alternative splicing of coding genes is an underappreciated regulatory mechanism and has been shown to play a role in diverse processes such as embryonic development, tumorigenesis, and resistance to chemical pharmaceutical treatments. Our objective was to elucidate the sex-specific alternative splicing differences in coding genes in the lung in vivo in a model of murine neonatal hyperoxic lung injury. Method(s): Neonatal male and female mice (C57BL/6) were exposed to hyperoxia (95% FiO2, PND 1-5: saccular stage of lung development) or room air and sacrificed on PND 7. Pulmonary gene expression was studied using RNA-seq on Illumina HiSeq 2500 platform. Data were mapped onto the murine genome build UCSC mm10 using TopHat2, and quantified using cufflinks2 and the GENCODE mouse reference. Alternative splicing was performed for skipped exons splicing events using the MISO pipeline. We compared the alternative splicing by sex between room air and hyperoxia exposure. We evaluated enriched pathways using hypergeometric distribution (p&lt;0.05) and the compendium of pathways Hallmark, Kegg, Reactome, and Gene Ontology, as compiled by MSigDB. Result(s): Alveolarization and angiogenesis was better preserved in female mice compared to similarly exposed male mice. Significant alternative splicing was observed in numerous genes between male and female mice at PND7 in room air and after hyperoxic treatment. 67 genes showed alternative splicing in room air, while 441 showed differences in the mice exposed to hyperoxia. Among 14 pathways enriched in alternatively spliced genes only in room air, we found differences in genes involved in collagen formation, such as Col24a1 and Col23a1, and PPARa signaling genes such as Med15 and Nrf1. Among 537 pathways enriched only in the hyperoxia group, genes involved in vascular endothelial signaling, including Fn1, Notch1, Mapk14, Itgb1bp1, Prkd1, Nrp2, and developmental genes, such as Rara, Ncoa2, Disc1, Chd7 were differentially regulated between male and female mice. Conclusion(s): Dysregulation via alternative splicing may contribute to the sex-specific differences in hyperoxia-induced inhibition of lung development and diseases, such as BPD. These differences could explain in part the mechanisms behind sex-specific differences in the incidence of BPD.</style></abstract><accession-num><style face="normal" font="default" size="100%">622966360</style></accession-num><auth-address><style face="normal" font="default" size="100%">K. Lingappan, Pediatrics, Baylor College of Medicine, Houston, TX, United States. E-mail: lingappa@bcm.edu</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><isbn><style face="normal" font="default" size="100%">1535-4970</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><number><style face="normal" font="default" size="100%">MeetingAbstracts
SP  -</style></number><volume><style face="normal" font="default" size="100%">197</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2018//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A6970</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed19&amp;NEWS=N&amp;AN=622966360</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">*alternative RNA splicing</style></keyword>,<keyword><style face="normal" font="default" size="100%">ambient air</style></keyword>,<keyword><style face="normal" font="default" size="100%">angiogenesis</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">C57BL 6 mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">carcinogenesis</style></keyword>,<keyword><style face="normal" font="default" size="100%">collagen synthesis</style></keyword>,<keyword><style face="normal" font="default" size="100%">controlled study</style></keyword>,<keyword><style face="normal" font="default" size="100%">developmental gene</style></keyword>,<keyword><style face="normal" font="default" size="100%">drug resistance</style></keyword>,<keyword><style face="normal" font="default" size="100%">embryo development</style></keyword>,<keyword><style face="normal" font="default" size="100%">exon</style></keyword>,<keyword><style face="normal" font="default" size="100%">female</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene expression</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene ontology</style></keyword>,<keyword><style face="normal" font="default" size="100%">genetic analyzer</style></keyword>,<keyword><style face="normal" font="default" size="100%">hyperoxia</style></keyword>,<keyword><style face="normal" font="default" size="100%">in vivo study</style></keyword>,<keyword><style face="normal" font="default" size="100%">incidence</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung development</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung injury</style></keyword>,<keyword><style face="normal" font="default" size="100%">male</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">*murine model</style></keyword>,<keyword><style face="normal" font="default" size="100%">newborn</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">pipeline</style></keyword>,<keyword><style face="normal" font="default" size="100%">regulatory mechanism</style></keyword>,<keyword><style face="normal" font="default" size="100%">saccule</style></keyword>,<keyword><style face="normal" font="default" size="100%">signal transduction</style></keyword>,<keyword><style face="normal" font="default" size="100%">beta1 integrin</style></keyword>,<keyword><style face="normal" font="default" size="100%">disrupted in schizophrenia 1 protein</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">mitogen activated protein kinase 14</style></keyword>,<keyword><style face="normal" font="default" size="100%">neuropilin 2</style></keyword>,<keyword><style face="normal" font="default" size="100%">Notch1 receptor</style></keyword>,<keyword><style face="normal" font="default" size="100%">nuclear receptor coactivator 2</style></keyword>,<keyword><style face="normal" font="default" size="100%">peroxisome proliferator activated receptor alpha</style></keyword>,<keyword><style face="normal" font="default" size="100%">protein kinase D</style></keyword>,<keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>8</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dautel S.</style></author>,<author><style face="normal" font="default" size="100%">Snowball J.</style></author>,<author><style face="normal" font="default" size="100%">Whitsett J.A.</style></author>,<author><style face="normal" font="default" size="100%">Perl A.T.</style></author>,<author><style face="normal" font="default" size="100%">Ahlfeld S.K.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Neonatal hyperoxia perturbs gene expression in murine PDGFR-alpha-expressing pulmonary interstitial fibroblasts</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Respiratory and Critical Care Medicine</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Rationale: Bronchopulmonary dysplasia (BPD) is a common chronic lung disorder affecting infants born prematurely. Impaired lung function results from inhibited alveolar septation causing alveolar simplification. Although the etiology is multifactorial, BPD is strongly associated with exposure of the immature lung to inflammation and hyperoxia. While the mechanisms governing alveolarization are poorly understood, alveolar interstitial fibroblasts that express Platelet Derived Growth Factor Receptor Alpha (PDGFRalpha) play an important role in matrix production and tissue remodeling during septation. In the present study we used a transcriptomic approach to assess changes in lung gene expression using a murine model of neonatal hyperoxia to elucidate acute and persistent effects of hyperoxia on PDGFRalpha+ pulmonary cells. Method(s): Newly-delivered C57BL6 mouse pups were exposed continuously to either hyperoxia (&gt;90% O2) or room air (RA) from birth through the first 7 postnatal days (P0-P7). On P7, hyperoxia-exposed mice were returned to RA and allowed to recover until P10. Using magnetic bead separation from single lung cell suspensions, cells expressing PDGFRalpha were obtained at P4 and P7 (acute hyperoxia exposure) and P10 (recovery from hyperoxia), processed for bulk RNA-Seq, and compared to RA controls. Transcriptomic data analysis identified differentially expressed genes between time-matched samples, during normal development (RA), as well as under hyperoxic conditions. Pathway analysis revealed enriched pathways relevant to septation. Changes in gene expression were used to predict upstream transcriptional regulators. Result(s): Neonatal hyperoxia caused significant, global changes in PDGFRalpha+ fibroblast gene expression: RNAs associated with oxidative stress (super oxygen dismutase, glutathione metabolism) were significantly increased, RNAs encoding key lung developmental growth factors (TGF-beta, PDGF, BMP, VEGF, FGF, IGF) were significantly decreased, and RNAs governing extracellular matrix production and remodeling (collagen, elastin, glycosaminoglycans, and proteinases) were significantly inhibited. Additionally, mis-expression of genes known to be important regulators of cell cycle (P21, CDKs, cyclins) indicated that hyperoxia inhibited cell cycle progression. Upstream analysis of perturbed genes predicted that Foxm1 serves as a master regulator of the cell cycle during alveolarization by inhibiting the G2/M checkpoint. Conclusion(s): Taken together, this study demonstrates that neonatal hyperoxia causes global, persistent changes in the gene expression in murine PDGFRalpha+ interstitial fibroblasts. We have identified key regulators of alveolar septation as potential therapeutic targets to optimize lung development following preterm birth.</style></abstract><accession-num><style face="normal" font="default" size="100%">622966279</style></accession-num><auth-address><style face="normal" font="default" size="100%">S. Dautel, University of Washington, Seattle, WA, United States. E-mail: sydney24@uw.edu</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><isbn><style face="normal" font="default" size="100%">1535-4970</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><number><style face="normal" font="default" size="100%">MeetingAbstracts
SP  -</style></number><volume><style face="normal" font="default" size="100%">197</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2018//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2018.197.1_MeetingAbstracts.A6967</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed19&amp;NEWS=N&amp;AN=622966279</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">ambient air</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">*C57BL 6 mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">cell cycle progression</style></keyword>,<keyword><style face="normal" font="default" size="100%">cell suspension</style></keyword>,<keyword><style face="normal" font="default" size="100%">controlled study</style></keyword>,<keyword><style face="normal" font="default" size="100%">data analysis</style></keyword>,<keyword><style face="normal" font="default" size="100%">extracellular matrix</style></keyword>,<keyword><style face="normal" font="default" size="100%">*fibroblast</style></keyword>,<keyword><style face="normal" font="default" size="100%">G2 phase cell cycle checkpoint</style></keyword>,<keyword><style face="normal" font="default" size="100%">global change</style></keyword>,<keyword><style face="normal" font="default" size="100%">glutathione metabolism</style></keyword>,<keyword><style face="normal" font="default" size="100%">*hyperoxia</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung alveolus cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung development</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">murine model</style></keyword>,<keyword><style face="normal" font="default" size="100%">newborn</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">oxidative stress</style></keyword>,<keyword><style face="normal" font="default" size="100%">prematurity</style></keyword>,<keyword><style face="normal" font="default" size="100%">*protein expression</style></keyword>,<keyword><style face="normal" font="default" size="100%">signal transduction</style></keyword>,<keyword><style face="normal" font="default" size="100%">transcription initiation</style></keyword>,<keyword><style face="normal" font="default" size="100%">collagen</style></keyword>,<keyword><style face="normal" font="default" size="100%">cyclin dependent kinase</style></keyword>,<keyword><style face="normal" font="default" size="100%">cycline</style></keyword>,<keyword><style face="normal" font="default" size="100%">elastin</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">fibroblast growth factor</style></keyword>,<keyword><style face="normal" font="default" size="100%">forkhead box protein M1</style></keyword>,<keyword><style face="normal" font="default" size="100%">glycosaminoglycan</style></keyword>,<keyword><style face="normal" font="default" size="100%">oxygen</style></keyword>,<keyword><style face="normal" font="default" size="100%">platelet derived growth factor</style></keyword>,<keyword><style face="normal" font="default" size="100%">*platelet derived growth factor alpha receptor</style></keyword>,<keyword><style face="normal" font="default" size="100%">proteinase</style></keyword>,<keyword><style face="normal" font="default" size="100%">transforming growth factor beta</style></keyword>,<keyword><style face="normal" font="default" size="100%">vasculotropin</style></keyword>,<keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>9</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mizikova I.</style></author>,<author><style face="normal" font="default" size="100%">Palumbo F.</style></author>,<author><style face="normal" font="default" size="100%">Morty R.</style></author>,<author><style face="normal" font="default" size="100%">Seeger W.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Gene regulatory roles for lysyl oxidases in the context of BPD</style></title><secondary-title><style face="normal" font="default" size="100%">European Respiratory Journal</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Lysyl oxidases are extracellular matrix (ECM) metabolizing enzymes with pathogenic roles in multiple diseases e.g. lung cancer fibrosis, and bronchopulmonary dysplasia (BPD). Recently, ECM-independent roles for lysyl oxidases have been proposed, including chromatin remodelling and transcriptional regulation. We aimed to explore the gene regulatory roles for lysyl oxidases in primary mouse lung fibroblasts. The gene regulatory potential of three predominant lysyl oxidases (Lox, Loxl1, and Loxl2) was investigated using a microarray approach, small interfering (si)RNA knockdown and lentivirus-mediated over-expression. In order to determine whether the lysyl oxidase activity is required for transcriptional regulation, primary mouse lung fibroblasts were treated with lysyl oxidase inhibitor beta-aminopropionitrile (BAPN) and the transcriptome was analysed by microarray. Potential correlations with gene expression in vitro were made with gene expression in vivo, in mouse model of BPD. We report, for the first time a transcriptomewide analysis of gene regulation by lysyl oxidases. In the context of primary mouse lung fibroblasts, siRNA knockdown of Lox, Loxl1, and Loxl2 deregulated the expression of 134, 3,761 and 3,554 genes, respectively. Identified lysyl oxidases target-genes relevant to lung development and BPD included Mmp3, Mmp9, Eln, Rarres1, Gdf10, Ifnb1, Cxcl2, and Cxcl9. The expression of target-genes in vivo correlated with the lysyl oxidases expression in a mouse model of BPD. Moreover, using BAPN, we demonstrated that the transcriptional regulation by lysyl oxidases was independent of catalytic activity both in vitro and in vivo, which is of importance in targeting the lysyl oxidases in a therapeutic context.</style></abstract><accession-num><style face="normal" font="default" size="100%">625791635</style></accession-num><auth-address><style face="normal" font="default" size="100%">I. Mizikova, Max Planck Institute for Heart and Lung Research Bad Nauheim, Germany</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1183/1393003.congress-2017.OA3232</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">1399-3003</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><number><style face="normal" font="default" size="100%">Supplement 61
SP  -</style></number><volume><style face="normal" font="default" size="100%">50</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2017//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://erj.ersjournals.com/content/50/suppl_61/OA3232</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed18&amp;NEWS=N&amp;AN=625791635</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">catalysis</style></keyword>,<keyword><style face="normal" font="default" size="100%">controlled study</style></keyword>,<keyword><style face="normal" font="default" size="100%">DNA microarray</style></keyword>,<keyword><style face="normal" font="default" size="100%">enzyme activity</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene overexpression</style></keyword>,<keyword><style face="normal" font="default" size="100%">in vitro study</style></keyword>,<keyword><style face="normal" font="default" size="100%">in vivo study</style></keyword>,<keyword><style face="normal" font="default" size="100%">Lentivirus</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung development</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung fibroblast</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse model</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">protein expression</style></keyword>,<keyword><style face="normal" font="default" size="100%">*protein function</style></keyword>,<keyword><style face="normal" font="default" size="100%">3 aminopropionitrile</style></keyword>,<keyword><style face="normal" font="default" size="100%">beta interferon</style></keyword>,<keyword><style face="normal" font="default" size="100%">CXCL2 chemokine</style></keyword>,<keyword><style face="normal" font="default" size="100%">CXCL9 chemokine</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">growth differentiation factor 10</style></keyword>,<keyword><style face="normal" font="default" size="100%">*protein lysine 6 oxidase</style></keyword>,<keyword><style face="normal" font="default" size="100%">small interfering RNA</style></keyword>,<keyword><style face="normal" font="default" size="100%">stromelysin</style></keyword>,<keyword><style face="normal" font="default" size="100%">transcriptome</style></keyword>,<keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>10</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Camp J.R.</style></author>,<author><style face="normal" font="default" size="100%">Quantius J.</style></author>,<author><style face="normal" font="default" size="100%">Lignelli E.</style></author>,<author><style face="normal" font="default" size="100%">Arndt P.</style></author>,<author><style face="normal" font="default" size="100%">Mizikova I.</style></author>,<author><style face="normal" font="default" size="100%">Sakkas E.</style></author>,<author><style face="normal" font="default" size="100%">Mayer K.</style></author>,<author><style face="normal" font="default" size="100%">Vadasz I.</style></author>,<author><style face="normal" font="default" size="100%">Richardson W.</style></author>,<author><style face="normal" font="default" size="100%">Ahlbrecht K.</style></author>,<author><style face="normal" font="default" size="100%">Herold S.</style></author>,<author><style face="normal" font="default" size="100%">Seeger W.</style></author>,<author><style face="normal" font="default" size="100%">Morty R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Late Breaking Abstract-The miR-34a/Pdgfra interaction can be targeted to correct defective alveolarization in experimental bronchopulmonary dysplasia</style></title><secondary-title><style face="normal" font="default" size="100%">European Respiratory Journal</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Bronchopulmonary dysplasia (BPD) is a chronic lung disease of premature neonates characterized by arrested lung alveolarization. MicroRNAs (miR) are poorly understood in the context of BPD. Here, a miR microarray on mouse lungs exposed to normoxia (21% O ) or hyperoxia (85% O ) revealed an up-regulation of the miR-34a expression (at least 1.5-fold at all time-points) in mouse lungs maintained under hyperoxic conditions. Mice treated with an antagomiR-34a almost doubled the total number of alveoli (2.1 +/- 0.4 x 10 ) and normalized the mean septal wall thickness (10.1 +/- 2.3 mum) under hyperoxic conditions compared to the number of alveoli (1.2 +/- 0.2 x 10 ) and septal wall thickness (17.8 +/- 3.9 mum) assessed by stereology in mice injected with scrambled antagomiR (SCR). Platelet-derived growth factor receptor (PDGFR)alpha, a target of miR-34a, has been reported to be crucial for myofibroblast transdifferentiation and normal lung alveolarization. Isolated PDGFRalpha cells by flow cytometry from mouse lungs exposed to 85% O for the first five days of life revealed an up-regulation of the miR-34a expression (3-fold). Mice injected with two target-site blockers, to block the miR-34a/Pdgfra mRNA interaction, increased the total number of alveoli (1.7 +/- 0.2 x 10 ) and normalized the septal wall thickness (11.6 +/- 1.2 mum) under hyperoxic conditions compared to the number of alveoli (1.3 +/- 0.1 x 10 ) and septal wall thickness (13.9 +/- 1.4 mum) observed in SCR-treated mice. In conclusion, the inhibition of miR-34a partially restored the total number of alveoli and normalised the septal wall thickness in mouse lungs maintained under hyperoxic conditions.</style></abstract><accession-num><style face="normal" font="default" size="100%">625790480</style></accession-num><auth-address><style face="normal" font="default" size="100%">J.R. Camp, Department of Lung Development and Remodelling, Max Planck Institute for Heart and Lung Research, Bad Nauheim, Germany</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1183/1393003.congress-2017.PA2808</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">1399-3003</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><number><style face="normal" font="default" size="100%">Supplement 61
SP  -</style></number><volume><style face="normal" font="default" size="100%">50</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2017//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://erj.ersjournals.com/content/50/suppl_61/PA2808</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed18&amp;NEWS=N&amp;AN=625790480</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">animal cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">cell transdifferentiation</style></keyword>,<keyword><style face="normal" font="default" size="100%">chronic lung disease</style></keyword>,<keyword><style face="normal" font="default" size="100%">controlled study</style></keyword>,<keyword><style face="normal" font="default" size="100%">DNA microarray</style></keyword>,<keyword><style face="normal" font="default" size="100%">flow cytometry</style></keyword>,<keyword><style face="normal" font="default" size="100%">hyperoxia</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung alveolus</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">myofibroblast</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">pancreas islet alpha cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">prematurity</style></keyword>,<keyword><style face="normal" font="default" size="100%">protein expression</style></keyword>,<keyword><style face="normal" font="default" size="100%">stereology</style></keyword>,<keyword><style face="normal" font="default" size="100%">thickness</style></keyword>,<keyword><style face="normal" font="default" size="100%">thrombocyte</style></keyword>,<keyword><style face="normal" font="default" size="100%">transcription initiation</style></keyword>,<keyword><style face="normal" font="default" size="100%">upregulation</style></keyword>,<keyword><style face="normal" font="default" size="100%">antagomir</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">messenger RNA</style></keyword>,<keyword><style face="normal" font="default" size="100%">*microRNA 34a</style></keyword>,<keyword><style face="normal" font="default" size="100%">*platelet derived growth factor alpha receptor</style></keyword>,<keyword><style face="normal" font="default" size="100%">conference abstract</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>11</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Turcatel G.</style></author>,<author><style face="normal" font="default" size="100%">Leguizamon S.</style></author>,<author><style face="normal" font="default" size="100%">Millette K.</style></author>,<author><style face="normal" font="default" size="100%">Dinkel C.</style></author>,<author><style face="normal" font="default" size="100%">Shim A.</style></author>,<author><style face="normal" font="default" size="100%">Thornton M.</style></author>,<author><style face="normal" font="default" size="100%">Asif A.</style></author>,<author><style face="normal" font="default" size="100%">Noe N.</style></author>,<author><style face="normal" font="default" size="100%">Lee H.</style></author>,<author><style face="normal" font="default" size="100%">Bartolin L.</style></author>,<author><style face="normal" font="default" size="100%">Grubbs B.</style></author>,<author><style face="normal" font="default" size="100%">Warburton D.</style></author>,<author><style face="normal" font="default" size="100%">Shi W.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">On the male disadvantage: Generation and characterization of a male specific mouse model of bronchopulmonary dysplasia</style></title><secondary-title><style face="normal" font="default" size="100%">Molecular Biology of the Cell</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">The proper development of both human and murine lungs relies on a precise temporal-spatial expression of growth factors including WNT, FGF, and TGF-beta family of ligands. Among these, Tgf-beta family is well known for its functions in relation to cell proliferation, differentiation, apoptosis, and epithelial-mesenchymal transition, which play key roles not only during development but also during tumor growth. Sex is a risk factor in several human lung diseases. Male infants have higher risk of developing bronchopulmonary dysplasia (BPD) as compared to females and idiopathic pulmonary fibrosis has higher incidence and worse outcome in male patients than in female patients. Sex hormones have been shown to modulated the severity of lung disease in animal models. For instance, the male hormone androgen exacerbates the bleomycin-induced lung fibrosis in female mice. Herein, we have induced the activation of the TGF-beta signaling pathway specifically in embryonic lung epithelium by crossing Ca-Tgf-beta-r1-Stopfl/fl (Constitutively active Tgf-beta-receptor-1) female mice with Ttf1-Cre male mice which produced a complex and lethal phenotype only in male fetuses. The phenotype displayed by the mutant male resembles the bronchopulmonary dysplasia disease displayed by human preterm infants and was not compatible with life. In contrast, mutant females were viable and showed either a weak phenotype or no phenotype at all. The lung epithelium of the mutant males showed increased number of progenitor Sox9 positive cells and genetic deletion of one allele of the Sox9 gene significantly reduced the severity of the phenotype in mutant male mice. Transcriptome profiling delivered important insights on the mechanism responsible for the lung phenotype in mutant male animals. Among the genes deregulated in the mutant male lung we recognized genes already known to be critical for the lung physiopathology such as Spock2 and Amantsl2 which are implicated to the pathogenesis of BPD in human and bronchial dysplasia in mice, respectively , Adamts18 which is a critical regulator of murine lung development and Adamdec1 which is over-expressed in patients with sarcoidosis. Finally, we showed that injection of estrogen in pregnant female mice was able to reverse the phenotype in the male lungs which suggests a hormonal dependency of the phenotype in the lung of the transgenic male mice. In conclusion, we have established a novel male sex-specific model of the TGF-beta signaling pathway that will be useful in studying how male sex can adversely affects lung development as well as neonatal pulmonary diseases in humans and to identify the sex-specific signaling pathways that give to male patients bearing lung diseases a prognostic disadvantage compared to female patients.</style></abstract><accession-num><style face="normal" font="default" size="100%">620042220</style></accession-num><auth-address><style face="normal" font="default" size="100%">G. Turcatel, Surgery, Children&apos;s Hospital of Los Angeles, Los Angeles, CA, United States</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1091/mbc.E17100618</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">1939-4586</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><number><style face="normal" font="default" size="100%">26
SP  -</style></number><volume><style face="normal" font="default" size="100%">28</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2017//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.molbiolcell.org/content/28/26/3727.full.pdf+html?with-ds=yes</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed18&amp;NEWS=N&amp;AN=620042220</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">adult</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">bleomycin-induced pulmonary fibrosis</style></keyword>,<keyword><style face="normal" font="default" size="100%">boy</style></keyword>,<keyword><style face="normal" font="default" size="100%">bronchus</style></keyword>,<keyword><style face="normal" font="default" size="100%">controlled study</style></keyword>,<keyword><style face="normal" font="default" size="100%">drug toxicity</style></keyword>,<keyword><style face="normal" font="default" size="100%">female</style></keyword>,<keyword><style face="normal" font="default" size="100%">fetus</style></keyword>,<keyword><style face="normal" font="default" size="100%">fetus lung</style></keyword>,<keyword><style face="normal" font="default" size="100%">fibrosing alveolitis</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene deletion</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene frequency</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene overexpression</style></keyword>,<keyword><style face="normal" font="default" size="100%">incidence</style></keyword>,<keyword><style face="normal" font="default" size="100%">injection</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung development</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung epithelium</style></keyword>,<keyword><style face="normal" font="default" size="100%">male</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">*mouse model</style></keyword>,<keyword><style face="normal" font="default" size="100%">newborn</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">phenotype</style></keyword>,<keyword><style face="normal" font="default" size="100%">pregnancy</style></keyword>,<keyword><style face="normal" font="default" size="100%">prematurity</style></keyword>,<keyword><style face="normal" font="default" size="100%">sarcoidosis</style></keyword>,<keyword><style face="normal" font="default" size="100%">TGF beta signaling</style></keyword>,<keyword><style face="normal" font="default" size="100%">transgene</style></keyword>,<keyword><style face="normal" font="default" size="100%">ADAMTS1 protein</style></keyword>,<keyword><style face="normal" font="default" size="100%">androgen</style></keyword>,<keyword><style face="normal" font="default" size="100%">calcium</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">estrogen</style></keyword>,<keyword><style face="normal" font="default" size="100%">hormone</style></keyword>,<keyword><style face="normal" font="default" size="100%">transcription factor Sox9</style></keyword>,<keyword><style face="normal" font="default" size="100%">transcriptome</style></keyword>,<keyword><style face="normal" font="default" size="100%">transforming growth factor beta receptor</style></keyword>,<keyword><style face="normal" font="default" size="100%">transforming growth factor beta receptor 1</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>12</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cho H.-Y.</style></author>,<author><style face="normal" font="default" size="100%">Miller-DeGraff L.</style></author>,<author><style face="normal" font="default" size="100%">Perrow L.</style></author>,<author><style face="normal" font="default" size="100%">Yamamoto M.</style></author>,<author><style face="normal" font="default" size="100%">Kleeberger S.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effect of prenatal antioxidant sulforaphane on developing lung disorder in neonatal mice</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Respiratory and Critical Care Medicine</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Rationale: Induction of cytoprotective genes by the transcription factor Nrf2 is essential in airway defense. Health benefits of dietary antioxidants, including a phytochemical Nrf2 agonist sulforaphane (SFN), have been demonstrated. However, effects of maternal antioxidant diet on postnatal airway disorders are not understood. Bronchopulmonary dysplasia (BPD) is a chronic lung disorder of preterm infants. Lack of Nrf2 augmented the BPD-like phenotypes in murine models. Method(s): To determine the influence of prenatally supplemented SFN on the pathogenesis of a model BPD, time-pregnant wild-type (Nrf2+/+) and Nrf2-deficient (Nrf2-/-) mice were orally given with SFN or vehicle (PBS) on embryonic (E) days 11, 13, 15, and 17. At postnatal day 1 when lungs were in saccular stage of development, pups were exposed to 100% O2 (hyperoxia) or air with foster dams for 3 days until injury was analyzed by bronchoalveolar lavage and histopathology at the end of exposure. Result(s): Hyperoxia-caused lung edema and inflammation and arrested saccular-to-alveolar transition were marginal in Nrf2+/+ neonates compared to the susceptible Nrf2-/- neonates. Prenatal SFN significantly improved hyperoxia-caused lung injury parameters and alveolar maturation in Nrf2-/- pups while it did not alter these phenotypes in the resistant Nrf2+/+ pups. cDNA microarray analysis determined that gestational SFN altered baseline postnatal lung genes in an Nrf2-dependent way. Prenatal SFN caused upregulation of cell growth and tissue development genes (Egr2, Myof, Ibsp) in air-exposed Nrf2 +/+pups, while it altered cell cycle, apoptosis, epithelial-mesenchymal transition, and angiogenesis genes (Tp53, Fgfr, Vegf, Ilk) in air-exposed Nrf2-/- pups. Transcriptome changes by gestational SFN also differed between two genotypes after hyperoxia. In Nrf2+/+pups, hyperoxia-increased immune genes (Lcn2, H2-D1, Cdh22) were downregulated by SFN, and vice versa for cell proliferation genes (Cdca2, Palmd). Prenatal SFN also upregulated Nrf2 effector antioxidants (Ephx1, Ggt7) against hyperoxia in these mice. In Nrf2-/- pups, many hyperoxia-induced inflammatory and cell-to-cell signaling genes (Clec7a, Selplg, Csf2rb) were suppressed by prenatal SFN. Althought gestational SFN supplementation affected lung transcriptomics differentially in Nrf2+/+and Nrf2-/- pups, inhibition of signaling molecules including MAPK, NF-kappaB and/or AP-1 was proposed to be involved in common. Conclusion(s): Gestational SFN protected developing lungs from BPD-like pathogenesis in the susceptible Nrf2-/- pups, supporting an Nrf2-independent defensive role of SFN. Transcriptome analyses suggested underlying molecular mechanisms of prenatal SFN. Together with transcriptome changes of embryonic lung and placenta at E18.5, results provide new insights into the influence of maternal antioxidant diet on fetal programming for postnatal respiratory health.</style></abstract><accession-num><style face="normal" font="default" size="100%">617710228</style></accession-num><auth-address><style face="normal" font="default" size="100%">H.-Y. Cho, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States. E-mail: cho2@niehs.nih.gov</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1164/ajrccmconference.2017.C77</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">1535-4970</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><volume><style face="normal" font="default" size="100%">195
SP  -</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2017//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A6401</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed18&amp;NEWS=N&amp;AN=617710228</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">angiogenesis</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">apoptosis</style></keyword>,<keyword><style face="normal" font="default" size="100%">cell proliferation</style></keyword>,<keyword><style face="normal" font="default" size="100%">diet</style></keyword>,<keyword><style face="normal" font="default" size="100%">disease model</style></keyword>,<keyword><style face="normal" font="default" size="100%">DNA transcription</style></keyword>,<keyword><style face="normal" font="default" size="100%">drug resistance</style></keyword>,<keyword><style face="normal" font="default" size="100%">embryo</style></keyword>,<keyword><style face="normal" font="default" size="100%">epithelial mesenchymal transition</style></keyword>,<keyword><style face="normal" font="default" size="100%">exposure</style></keyword>,<keyword><style face="normal" font="default" size="100%">female</style></keyword>,<keyword><style face="normal" font="default" size="100%">fetus</style></keyword>,<keyword><style face="normal" font="default" size="100%">fetus lung</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene inactivation</style></keyword>,<keyword><style face="normal" font="default" size="100%">genotype</style></keyword>,<keyword><style face="normal" font="default" size="100%">histopathology</style></keyword>,<keyword><style face="normal" font="default" size="100%">hyperoxia</style></keyword>,<keyword><style face="normal" font="default" size="100%">inflammatory cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung edema</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung injury</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung lavage</style></keyword>,<keyword><style face="normal" font="default" size="100%">maturation</style></keyword>,<keyword><style face="normal" font="default" size="100%">microarray analysis</style></keyword>,<keyword><style face="normal" font="default" size="100%">murine model</style></keyword>,<keyword><style face="normal" font="default" size="100%">newborn</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">oral drug administration</style></keyword>,<keyword><style face="normal" font="default" size="100%">phenotype</style></keyword>,<keyword><style face="normal" font="default" size="100%">placenta</style></keyword>,<keyword><style face="normal" font="default" size="100%">pregnancy</style></keyword>,<keyword><style face="normal" font="default" size="100%">prematurity</style></keyword>,<keyword><style face="normal" font="default" size="100%">saccule</style></keyword>,<keyword><style face="normal" font="default" size="100%">signal transduction</style></keyword>,<keyword><style face="normal" font="default" size="100%">transcriptomics</style></keyword>,<keyword><style face="normal" font="default" size="100%">upregulation</style></keyword>,<keyword><style face="normal" font="default" size="100%">wild type</style></keyword>,<keyword><style face="normal" font="default" size="100%">*antioxidant</style></keyword>,<keyword><style face="normal" font="default" size="100%">CD131 antigen</style></keyword>,<keyword><style face="normal" font="default" size="100%">complementary DNA</style></keyword>,<keyword><style face="normal" font="default" size="100%">dectin 1</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">fibroblast growth factor receptor</style></keyword>,<keyword><style face="normal" font="default" size="100%">immunoglobulin enhancer binding protein</style></keyword>,<keyword><style face="normal" font="default" size="100%">mitogen activated protein kinase</style></keyword>,<keyword><style face="normal" font="default" size="100%">oxygen</style></keyword>,<keyword><style face="normal" font="default" size="100%">P selectin glycoprotein ligand 1</style></keyword>,<keyword><style face="normal" font="default" size="100%">protein p53</style></keyword>,<keyword><style face="normal" font="default" size="100%">sulforaphane</style></keyword>,<keyword><style face="normal" font="default" size="100%">transcription factor AP 1</style></keyword>,<keyword><style face="normal" font="default" size="100%">transcription factor Nrf2</style></keyword>,<keyword><style face="normal" font="default" size="100%">transcriptome</style></keyword>,<keyword><style face="normal" font="default" size="100%">vasculotropin</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>13</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wedgwood, Stephen</style></author>,<author><style face="normal" font="default" size="100%">Warford, Cris</style></author>,<author><style face="normal" font="default" size="100%">Agvateesiri, Sharleen C</style></author>,<author><style face="normal" font="default" size="100%">Thai, Phung</style></author>,<author><style face="normal" font="default" size="100%">Berkelhamer, Sara K</style></author>,<author><style face="normal" font="default" size="100%">Perez, Marta</style></author>,<author><style face="normal" font="default" size="100%">Underwood, Mark A</style></author>,<author><style face="normal" font="default" size="100%">Steinhorn, Robin H</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Postnatal growth restriction augments oxygen-induced pulmonary hypertension in a neonatal rat model of bronchopulmonary dysplasia.</style></title><secondary-title><style face="normal" font="default" size="100%">Pediatric research</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">BACKGROUND: Prematurity and fetal growth restriction are risk factors for pulmonary hypertension (PH) in infants with bronchopulmonary dysplasia (BPD). Neonatal rats develop PH and vascular remodeling when exposed to hyperoxia. We hypothesize that postnatal growth restriction (PNGR) due to under-nutrition increases the severity of PH induced by hyperoxia in neonatal rats., METHODS: Pups were randomized at birth to litters maintained in room air or 75% oxygen (hyperoxia), together with litters of normal milk intake (10 pups) or PNGR (17 pups). After 14 d, right ventricular hypertrophy (RVH) was assessed by Fulton&apos;s index (right ventricular weight/left ventricular plus septal weight) and PH by echocardiography. Lungs were analyzed by immunohistochemistry, morphometrics, western blotting, and metabolomics., RESULTS: Hyperoxia and PNGR each significantly increased pulmonary arterial pressure, RVH and pulmonary arterial medial wall thickness, and significantly decreased pulmonary vessel number. These changes were significantly augmented in pups exposed to both insults. Hyperoxia and PNGR both significantly decreased expression of proteins involved in lung development and vasodilation., CONCLUSION: PNGR induces right ventricular and pulmonary vascular remodeling and augments the effects of oxygen in neonatal rats. This may be a powerful tool to investigate the mechanisms that induce PH in low-birth-weight preterm infants with BPD.</style></abstract><access-date><style face="normal" font="default" size="100%">20160810//</style></access-date><auth-address><style face="normal" font="default" size="100%">United States</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Ovid MEDLINE(R) &lt;2016&gt;</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1038/pr.2016.164</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">0031-3998</style></isbn><number><style face="normal" font="default" size="100%">6</style></number><volume><style face="normal" font="default" size="100%">80</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2016//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=med13&amp;NEWS=N&amp;AN=27509009</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">Animals</style></keyword>,<keyword><style face="normal" font="default" size="100%">Animals, Newborn</style></keyword>,<keyword><style face="normal" font="default" size="100%">*Bronchopulmonary Dysplasia/et [Etiology]</style></keyword>,<keyword><style face="normal" font="default" size="100%">Bronchopulmonary Dysplasia/pa [Pathology]</style></keyword>,<keyword><style face="normal" font="default" size="100%">Bronchopulmonary Dysplasia/pp [Physiopathology]</style></keyword>,<keyword><style face="normal" font="default" size="100%">Caloric Restriction/ae [Adverse Effects]</style></keyword>,<keyword><style face="normal" font="default" size="100%">Disease Models, Animal</style></keyword>,<keyword><style face="normal" font="default" size="100%">Disease Susceptibility</style></keyword>,<keyword><style face="normal" font="default" size="100%">Female</style></keyword>,<keyword><style face="normal" font="default" size="100%">Gene Expression</style></keyword>,<keyword><style face="normal" font="default" size="100%">Growth and Development</style></keyword>,<keyword><style face="normal" font="default" size="100%">Hyperoxia/co [Complications]</style></keyword>,<keyword><style face="normal" font="default" size="100%">*Hypertension, Pulmonary/et [Etiology]</style></keyword>,<keyword><style face="normal" font="default" size="100%">Hypertension, Pulmonary/pa [Pathology]</style></keyword>,<keyword><style face="normal" font="default" size="100%">Hypertension, Pulmonary/pp [Physiopathology]</style></keyword>,<keyword><style face="normal" font="default" size="100%">Hypertrophy, Right Ventricular/et [Etiology]</style></keyword>,<keyword><style face="normal" font="default" size="100%">Hypertrophy, Right Ventricular/pa [Pathology]</style></keyword>,<keyword><style face="normal" font="default" size="100%">Hypertrophy, Right Ventricular/pp [Physiopathology]</style></keyword>,<keyword><style face="normal" font="default" size="100%">Pregnancy</style></keyword>,<keyword><style face="normal" font="default" size="100%">Rats</style></keyword>,<keyword><style face="normal" font="default" size="100%">Rats, Sprague-Dawley</style></keyword>,<keyword><style face="normal" font="default" size="100%">Signal Transduction</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>14</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Moghieb A.M.</style></author>,<author><style face="normal" font="default" size="100%">Clair G.</style></author>,<author><style face="normal" font="default" size="100%">Kyle J.</style></author>,<author><style face="normal" font="default" size="100%">Kim Y.-M.</style></author>,<author><style face="normal" font="default" size="100%">Zink E.</style></author>,<author><style face="normal" font="default" size="100%">Petyuk V.A.</style></author>,<author><style face="normal" font="default" size="100%">Corley R.</style></author>,<author><style face="normal" font="default" size="100%">Ansong C.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Time-resolved proteome, metabolome and lipidome profiling of normal lung development</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Respiratory and Critical Care Medicine</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Rationale. Lung immaturity is associated with numerous complications, including neonatal respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD) which are a key factor affecting mortality and morbidity in preterm babies worldwide. The cellular and molecular pathways that regulate lung development process are still poorly understood and critical to aid lung repair and regeneration in premature infants. The systematic investigations of the regulatory processes during the formation of the tracheobronchial tree and the alveoli will help to better understand the specification mechanisms that drive normal lung development and maturation. Methods. In this study, we applied unbiased mass spectrometry-based multi-omics approaches (i.e. proteomics, metabolomics, and lipidomics) to characterize the molecular constituents of the mouse lung during normal development. We used whole lung tissue homogenates from mice at gestational day 16.5 &amp; 18.5 (E16.5 &amp; E18.5), postnatal day 7 (P7) and postnatal day 28 (P28) with n = 4 per timepoint. The aqueous polar metabolites, proteins, and lipids were extracted from the same sample using a modified Folch extraction method (metabolite, protein, and lipid extraction, MPLEx), then introduced into GC-MS (metabolomics) and LC-MS/MS (proteomics and lipidomics) analyses. Results. Our integrative multi-omics approaches have enabled comprehensive profiling of the processes underlying lung development in mouse. We have identified 8178 proteins, 159 metabolites, and 442 lipids which are involved in multiple stage specific changes in structure and function of Lung development over the time. The analysis showed several different expression patterns across developmental stages for each omics data. For example protein profiling indicated increased cell cycle activity and metabolism of proteins (i.e. increased proliferation) early in development while immune system components were increased as well as lipid metabolism and energy metabolism later. The proteomics observations were supported by global metabolite profiling which detected higher pools of free amino acids at early timepoints of lung development and increased abundance of glycolysis intermediates at later timepoints supporting the notion of increased proliferation/protein metabolism at early timepoints and increased energy metabolism at later timepoints. Conclusion. Understanding the molecular details of lung development will greatly help to ameliorate morbidity and mortality in premature infants. This work forms part of the LungMAP initiative to establish a molecular atlas of the mouse and the human lung.</style></abstract><accession-num><style face="normal" font="default" size="100%">617710167</style></accession-num><auth-address><style face="normal" font="default" size="100%">A.M. Moghieb, Pacific Northwest National Laboratory, Richland, WA, United States</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1164/ajrccmconference.2017.C107</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">1535-4970</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><volume><style face="normal" font="default" size="100%">195
SP  -</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2017//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A6922</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed18&amp;NEWS=N&amp;AN=617710167</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">cell proliferation</style></keyword>,<keyword><style face="normal" font="default" size="100%">developmental stage</style></keyword>,<keyword><style face="normal" font="default" size="100%">energy metabolism</style></keyword>,<keyword><style face="normal" font="default" size="100%">extraction</style></keyword>,<keyword><style face="normal" font="default" size="100%">glycolysis</style></keyword>,<keyword><style face="normal" font="default" size="100%">human versus animal comparison</style></keyword>,<keyword><style face="normal" font="default" size="100%">immune system</style></keyword>,<keyword><style face="normal" font="default" size="100%">lipid metabolism</style></keyword>,<keyword><style face="normal" font="default" size="100%">lipidomics</style></keyword>,<keyword><style face="normal" font="default" size="100%">liquid chromatography-mass spectrometry</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung alveolus</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung development</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung function</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung parenchyma</style></keyword>,<keyword><style face="normal" font="default" size="100%">mass fragmentography</style></keyword>,<keyword><style face="normal" font="default" size="100%">maturation</style></keyword>,<keyword><style face="normal" font="default" size="100%">metabolite</style></keyword>,<keyword><style face="normal" font="default" size="100%">*metabolome</style></keyword>,<keyword><style face="normal" font="default" size="100%">metabolomics</style></keyword>,<keyword><style face="normal" font="default" size="100%">morbidity</style></keyword>,<keyword><style face="normal" font="default" size="100%">mortality</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">prematurity</style></keyword>,<keyword><style face="normal" font="default" size="100%">protein metabolism</style></keyword>,<keyword><style face="normal" font="default" size="100%">proteomics</style></keyword>,<keyword><style face="normal" font="default" size="100%">tissue homogenate</style></keyword>,<keyword><style face="normal" font="default" size="100%">tracheobronchial tree</style></keyword>,<keyword><style face="normal" font="default" size="100%">amino acid</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lipidome</style></keyword>,<keyword><style face="normal" font="default" size="100%">*proteome</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>15</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sun M.</style></author>,<author><style face="normal" font="default" size="100%">Chen T.</style></author>,<author><style face="normal" font="default" size="100%">Patel S.</style></author>,<author><style face="normal" font="default" size="100%">Ramchandran R.</style></author>,<author><style face="normal" font="default" size="100%">Raj J.U.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Microrna-133A/B plays a role in hyperoxia-induced decreased lung vascularization and pulmonary hypertension in neonatal mice</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Respiratory and Critical Care Medicine</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Rationale: Bronchopulmonary dysplasia (BPD) is characterized by decreased lung vascularization and alveolar simplification, and severe BPD is associated with pulmonary hypertension (PH). MicroRNAs (miRNA) are short, non-encoding RNAs that post-transcriptionally regulate gene expression. Currently, the role of miRNA in the development of BPD and PH in BPD is not fully understood. In this study, we wished to identify miRNA that contribute to hyperoxia-induced decreased lung vascularization and PH. Method(s): Newborn mice were exposed to hyperoxia (75% O2) for 2 weeks (T1) and then allowed to recover in room air for an additional 4 weeks until 6 weeks of age (T2). Lung alveolar and vascular development, right ventricular hypertrophy (RVH), and vessel remodeling were measured at both T1 and T2 time points. Right ventricular systolic pressure (RVSP) was measured at T2 only. miRNA expression profiling was performed with T1 and T2 lungs using a microarray platform and validated with qPCR. Human pulmonary artery endothelial cells and smooth muscle cells (HPAEC and HPASMC) were transfected with candidate miRNA mimics and inhibitors and exposed to normoxia or hyperoxia (95% O2). Cell proliferation, tube formation, and angiogenic factor expression were measured in HPAEC, while proliferation and smooth muscle cell (SMC) marker protein expression were measured in HPASMC. Result(s): Mice exposed to 2 weeks of hyperoxia exhibited decreased alveolarization and vascularization at T1, which persisted at T2, consistent with a BPD phenotype. At T2, these mice had developed PH, displaying RVH, increased arterial wall thickness, and elevated RVSP compared to control mice. From the miRNA microarray data, we found that miR-133a and miR-133b expression was significantly decreased in both T1 and T2 lungs after hyperoxia. HPAEC exposed to hyperoxia showed decreased proliferation and fewer loops and branches in a tube formation assay. HPAEC that were transfected with miR-133a/b inhibitors in normoxia also had fewer loops and branches in a tube formation assay. Transfection with miR-133a/b mimics restored cell proliferation and loop and branch formation in hyperoxic HPAEC. In normoxia, miR-133a/b mimics induced angiogenic factor expression in HPAEC. In normoxic HPASMC, miR-133a/b mimics decreased proliferation and induced SMC marker expression. Conclusion(s): Our results suggest that decreased expression of miR-133 induced by hyperoxia plays a role in the decreased vascularization of the BPD phenotype by suppressing PAEC proliferation and angiogenesis. Decreased expression of miR-133 may also contribute to the subsequent PH phenotype in our model by inducing proliferation and dedifferentiation in PASMC.</style></abstract><accession-num><style face="normal" font="default" size="100%">617709934</style></accession-num><auth-address><style face="normal" font="default" size="100%">M. Sun, University of Illinois at Chicago, Chicago, IL, United States</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1164/ajrccmconference.2017.C77</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">1535-4970</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><volume><style face="normal" font="default" size="100%">195
SP  -</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2017//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A6387</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed18&amp;NEWS=N&amp;AN=617709934</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">ambient air</style></keyword>,<keyword><style face="normal" font="default" size="100%">angiogenesis</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">arterial wall thickness</style></keyword>,<keyword><style face="normal" font="default" size="100%">cell dedifferentiation</style></keyword>,<keyword><style face="normal" font="default" size="100%">cell proliferation</style></keyword>,<keyword><style face="normal" font="default" size="100%">controlled study</style></keyword>,<keyword><style face="normal" font="default" size="100%">disease model</style></keyword>,<keyword><style face="normal" font="default" size="100%">DNA microarray</style></keyword>,<keyword><style face="normal" font="default" size="100%">endothelium cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">exposure</style></keyword>,<keyword><style face="normal" font="default" size="100%">female</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene expression profiling</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene expression regulation</style></keyword>,<keyword><style face="normal" font="default" size="100%">genetic transfection</style></keyword>,<keyword><style face="normal" font="default" size="100%">heart right ventricle hypertrophy</style></keyword>,<keyword><style face="normal" font="default" size="100%">*hyperoxia</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">male</style></keyword>,<keyword><style face="normal" font="default" size="100%">newborn</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">phenotype</style></keyword>,<keyword><style face="normal" font="default" size="100%">protein expression</style></keyword>,<keyword><style face="normal" font="default" size="100%">*pulmonary hypertension</style></keyword>,<keyword><style face="normal" font="default" size="100%">smooth muscle cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">systolic blood pressure</style></keyword>,<keyword><style face="normal" font="default" size="100%">*vascularization</style></keyword>,<keyword><style face="normal" font="default" size="100%">angiogenic factor</style></keyword>,<keyword><style face="normal" font="default" size="100%">cell marker</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">*microRNA</style></keyword>,<keyword><style face="normal" font="default" size="100%">oxygen</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>16</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lingappan K.</style></author>,<author><style face="normal" font="default" size="100%">Zhang Y.</style></author>,<author><style face="normal" font="default" size="100%">Maity S.</style></author>,<author><style face="normal" font="default" size="100%">Jiang W.</style></author>,<author><style face="normal" font="default" size="100%">Wang L.</style></author>,<author><style face="normal" font="default" size="100%">Coarfa C.</style></author>,<author><style face="normal" font="default" size="100%">Moorthy B.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Sex-specific differences in the transcriptome and epigenome in neonatal hyperoxic lung injury: Implications for bronchopulmonary dysplasia</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Respiratory and Critical Care Medicine</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Rationale: Male sex is considered an independent predictor for the development of BPD. BPD is characterized by impaired alveolar secondary septation and vascular growth. Exposure to high concentrations of oxygen (hyperoxia) contributes to its development. The reasons underlying sexually dimorphic outcomes in premature neonates are not known. In this study, we employed a non-biased approach to measure global changes in gene expression and DNA methylation following hyperoxia exposure in male and female mice. Method(s): Neonatal male and female mice (C57BL/6) were exposed to hyperoxia (95% FiO2, PND 1-5: saccular stage) and sacrificed on PND 7 and 21. Pulmonary gene expression was studied using RNA-seq on Illumina HiSeq 2500 platform. Data was mapped to the mouse genome using TopHat2, and quantified using Cufflinks2. Gene expression data was quantile normalized and analyzed using the R statistical software (Version 3.2.1). A combination of selection criteria comprising nominal p-values &lt;0.05 and linear fold change greater or lesser than 1.25 was used to generate differential expressed genes (DEGs) profiles. Enriched pathways and processes were inferred using the hypergeometric distribution, and various gene set collections as compiled in the Molecular Signature Database compendium. To detect and quantify DNA methylation, we performed 5-methylcytosine ELISA on lung DNA samples (PND 21). Result(s): A total of 119 (up-regulated (UR): 40, down-regulated (DR): 70) and 198 (UR: 117, DR: 81) genes were differentially expressed following hyperoxia in neonatal female mice at PND7 and PND21 respectively. Pathway analysis revealed differential sex-specific modulation of key pathways on PND7 and PND21. In the early repair phase (PND7), myogenesis, epithelial-mesenchymal transition, Notch signaling and angiogenesis were down regulated in males compared to females. In the late repair phase (PND21), females showed down regulation in the cellular defense response, allograft rejection and PD1 signaling compared to males. Hyperoxia decreased DNA methylation in both male and female mice but the decrease was more significant in male mice compared to similarly exposed females. Conclusion(s): Target genes in myogenesis, epithelial-mesenchymal transition, Notch signaling and angiogenesis in the early phase after hyperoxia exposure and cellular defense response, allograft rejection and PD1 signaling pathways may explain the differences in susceptibility of male and female neonatal mice to HLI. Differences in the epigenome partly though DNA methylation may explain the changes in gene expression responsible for the differential pathway modulation described above. These findings provide novel insights in the differential sex-specific modulation of the pulmonary transcriptome in neonatal hyperoxic lung injury.</style></abstract><accession-num><style face="normal" font="default" size="100%">617707013</style></accession-num><auth-address><style face="normal" font="default" size="100%">K. Lingappan, Baylor College of Medicine, Houston, TX, United States. E-mail: lingappa@bcm.edu</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1164/ajrccm-conference.2017.D28</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">1535-4970</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><volume><style face="normal" font="default" size="100%">195
SP  -</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2017//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A7241</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed18&amp;NEWS=N&amp;AN=617707013</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">angiogenesis</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">C57BL 6 mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">data base</style></keyword>,<keyword><style face="normal" font="default" size="100%">DNA methylation</style></keyword>,<keyword><style face="normal" font="default" size="100%">*DNA transcription</style></keyword>,<keyword><style face="normal" font="default" size="100%">down regulation</style></keyword>,<keyword><style face="normal" font="default" size="100%">enzyme linked immunosorbent assay</style></keyword>,<keyword><style face="normal" font="default" size="100%">*epigenetics</style></keyword>,<keyword><style face="normal" font="default" size="100%">epithelial mesenchymal transition</style></keyword>,<keyword><style face="normal" font="default" size="100%">exposure</style></keyword>,<keyword><style face="normal" font="default" size="100%">female</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene expression regulation</style></keyword>,<keyword><style face="normal" font="default" size="100%">genetic analyzer</style></keyword>,<keyword><style face="normal" font="default" size="100%">genetic susceptibility</style></keyword>,<keyword><style face="normal" font="default" size="100%">global change</style></keyword>,<keyword><style face="normal" font="default" size="100%">graft rejection</style></keyword>,<keyword><style face="normal" font="default" size="100%">hyperoxia</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung injury</style></keyword>,<keyword><style face="normal" font="default" size="100%">male</style></keyword>,<keyword><style face="normal" font="default" size="100%">modulation</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">muscle development</style></keyword>,<keyword><style face="normal" font="default" size="100%">newborn</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">prematurity</style></keyword>,<keyword><style face="normal" font="default" size="100%">quantitative study</style></keyword>,<keyword><style face="normal" font="default" size="100%">saccule</style></keyword>,<keyword><style face="normal" font="default" size="100%">software</style></keyword>,<keyword><style face="normal" font="default" size="100%">statistical significance</style></keyword>,<keyword><style face="normal" font="default" size="100%">5 methylcytosine</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">Notch receptor</style></keyword>,<keyword><style face="normal" font="default" size="100%">*transcriptome</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>17</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Espinoza C.R.</style></author>,<author><style face="normal" font="default" size="100%">Chhabra D.</style></author>,<author><style face="normal" font="default" size="100%">Nicola T.</style></author>,<author><style face="normal" font="default" size="100%">Ambalavanan N.</style></author>,<author><style face="normal" font="default" size="100%">Hagood J.S.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Genome-wide DNA methylation analysis at different stages of normal mouse lung development</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Respiratory and Critical Care Medicine</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Rationale: Normal lung alveolar septation is a complex process that involves the spatial and temporal integration of several signals from multiple cross-talking pathways. Its disruption causes several diseases including bronchopulmonary dysplasia (BPD) which affects infants born prematurely. Despite significant progress in our understanding of the normal lung alveolar septation process, the molecular mechanisms that govern it are incompletely understood. The aim of this study was to assess genome-wide changes in DNA methylation during the alveolar phase of lung development. Method(s): Mouse genomic DNA from lung tissues was isolated from Laser-capture microdissected (LCM) samples at different time points during lung development: saccular stage (P0.5, and P2.5) and alveolar stage (P7, P10, P19 and P28). Three biological samples per time point were analyzed by Methylated DNA Immunoprecipitation-Next-generation sequencing (MeDIP-seq) to determine genome-wide CpG methylation. MEDIP-seq libraries were constructed using 125 ng of DNA. Libraries were uploaded onto an Illumina HiSeq 4000 platform for ultra deep sequencing with single reads of 50 bases. Forty million reads per sample were sequenced. Result(s): Overall, MEDIP-seq data show that CpG methylation changes over time. GO enrichment analyses indicate that metabolic processes, binding, and catalytic activities are high in all time points. Transmembrane transport goes up at P0.5, then down, then up again at P7, P19 and P28. Phosphorous metabolism prominent at P0.5, P7, P10 and P28. Single-organism localization up at P7, P10 and P19. Furthermore, by performing genome-wide differential coverage analysis, we were able to identify a set of genes implicated in cell growth, development, or differentiation that were differentially methylated at several time points during lung development. Conclusion(s): Early changes in DNA methylation seems to initiate and shape lung alveolar development.</style></abstract><accession-num><style face="normal" font="default" size="100%">617706848</style></accession-num><auth-address><style face="normal" font="default" size="100%">C.R. Espinoza, University of California San Diego, San Diego, CA, United States. E-mail: c2espinoza@ucsd.edu</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1164/ajrccm-conference.2017.A75</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">1535-4970</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><volume><style face="normal" font="default" size="100%">195
SP  -</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2017//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.atsjournals.org/doi/pdf/10.1164/ajrccm-conference.2017.195.1_MeetingAbstracts.A7592</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed18&amp;NEWS=N&amp;AN=617706848</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">animal tissue</style></keyword>,<keyword><style face="normal" font="default" size="100%">case report</style></keyword>,<keyword><style face="normal" font="default" size="100%">catalysis</style></keyword>,<keyword><style face="normal" font="default" size="100%">cell growth</style></keyword>,<keyword><style face="normal" font="default" size="100%">chemical binding</style></keyword>,<keyword><style face="normal" font="default" size="100%">differentiation</style></keyword>,<keyword><style face="normal" font="default" size="100%">*DNA methylation</style></keyword>,<keyword><style face="normal" font="default" size="100%">DNA structure</style></keyword>,<keyword><style face="normal" font="default" size="100%">*genome</style></keyword>,<keyword><style face="normal" font="default" size="100%">growth curve</style></keyword>,<keyword><style face="normal" font="default" size="100%">immunoprecipitation</style></keyword>,<keyword><style face="normal" font="default" size="100%">laser</style></keyword>,<keyword><style face="normal" font="default" size="100%">library</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung development</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung parenchyma</style></keyword>,<keyword><style face="normal" font="default" size="100%">next generation sequencing</style></keyword>,<keyword><style face="normal" font="default" size="100%">saccule</style></keyword>,<keyword><style face="normal" font="default" size="100%">genomic DNA</style></keyword>,<keyword><style face="normal" font="default" size="100%">phosphorus</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>18</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Chao C.-M.</style></author>,<author><style face="normal" font="default" size="100%">Yahya F.</style></author>,<author><style face="normal" font="default" size="100%">Moiseenko A.</style></author>,<author><style face="normal" font="default" size="100%">Shrestha A.</style></author>,<author><style face="normal" font="default" size="100%">Ahmadvand N.</style></author>,<author><style face="normal" font="default" size="100%">Quantius J.</style></author>,<author><style face="normal" font="default" size="100%">Wilhelm J.</style></author>,<author><style face="normal" font="default" size="100%">El-Agha E.</style></author>,<author><style face="normal" font="default" size="100%">Zimmer K.-P.</style></author>,<author><style face="normal" font="default" size="100%">Bellusci S.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Fgf10 deficiency leads to disturbed formation of alveolar epithelial cell type II (AEC II) which causes lethality in a mouse model of bronchopulmonary dysplasia</style></title><secondary-title><style face="normal" font="default" size="100%">Molecular and Cellular Pediatrics</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Background Inflammation-induced FGF10 protein deficiency is associated with bronchopulmonary dysplasia (BPD), a chronic lung disease of prematurely born infants characterized by arrested alveolar development. So far, experimental evidence for a direct role of FGF10 in BPD is lacking. Methods and Results Using the hyperoxia-induced neonatal lung injury as a mouse model of BPD, the impact of Fgf10 deficiency in Fgf10(+/-) vs. Fgf10(+/+) pups was investigated. In normoxia, no lethality of Fgf10(+/+) and Fgf10(+/-) pups is observed. By contrast, 100% of Fgf10(+/-) pups died within 8 days of hyperoxic injury, with lethality starting at day 5, while Fgf10(+/+) pups were all alive. Lungs of pups from the two genotypes were collected on postnatal day 3 following normoxia or hyperoxia exposure for further analysis. In hyperoxia, Fgf10(+/-) lungs exhibited increased hypoalveolarization. Analysis by FACS of the Fgf10(+/-) vs. control lungs in normoxia, revealed decreased alveolar epithelial type II (AECII) cells over total EpCAM-positive cells ratio. In addition, gene array analysis indicated reduced AECII and increased AECI transcriptomic signatures in isolated AECII cells from Fgf10(+/-) lungs. Such imbalance in differentiation is also seen in hyperoxia and associated with reduced mature surfactant protein B and C expression. Attenuation of FGFR2b ligands activity postnatally in the context of hyperoxia also leads to increased lethality with decreased surfactant expression. Conclusions Fgf10 deficiency affects quantitatively and qualitatively the formation of AECII cells. In addition, FGFR2b ligands (including FGF10) are also important for repair after hyperoxia exposure in neonates. Deficient AECII cells could be an additional complication for patients with BPD.</style></abstract><accession-num><style face="normal" font="default" size="100%">616934541</style></accession-num><auth-address><style face="normal" font="default" size="100%">C.-M. Chao, Excellence Cluster Cardio-Pulmonary System, Giesen, Germany</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><electronic-resource-num><style face="normal" font="default" size="100%">https://dx.doi.org/10.1186/s40348-017-0071-0</style></electronic-resource-num><isbn><style face="normal" font="default" size="100%">2194-7791</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><number><style face="normal" font="default" size="100%">Supplement 1
SP  -</style></number><volume><style face="normal" font="default" size="100%">4</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2017//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed18&amp;NEWS=N&amp;AN=616934541</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">animal cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal experiment</style></keyword>,<keyword><style face="normal" font="default" size="100%">animal model</style></keyword>,<keyword><style face="normal" font="default" size="100%">attenuation</style></keyword>,<keyword><style face="normal" font="default" size="100%">complication</style></keyword>,<keyword><style face="normal" font="default" size="100%">controlled study</style></keyword>,<keyword><style face="normal" font="default" size="100%">differentiation</style></keyword>,<keyword><style face="normal" font="default" size="100%">DNA microarray</style></keyword>,<keyword><style face="normal" font="default" size="100%">exposure</style></keyword>,<keyword><style face="normal" font="default" size="100%">female</style></keyword>,<keyword><style face="normal" font="default" size="100%">flow cytometry</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene expression regulation</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene inactivation</style></keyword>,<keyword><style face="normal" font="default" size="100%">genotype</style></keyword>,<keyword><style face="normal" font="default" size="100%">hyperoxia</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lethality</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung alveolus epithelium cell</style></keyword>,<keyword><style face="normal" font="default" size="100%">*lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung injury</style></keyword>,<keyword><style face="normal" font="default" size="100%">male</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">*mouse model</style></keyword>,<keyword><style face="normal" font="default" size="100%">newborn</style></keyword>,<keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword>,<keyword><style face="normal" font="default" size="100%">endogenous compound</style></keyword>,<keyword><style face="normal" font="default" size="100%">epithelial cell adhesion molecule</style></keyword>,<keyword><style face="normal" font="default" size="100%">*fibroblast growth factor 10</style></keyword>,<keyword><style face="normal" font="default" size="100%">keratinocyte growth factor receptor</style></keyword>,<keyword><style face="normal" font="default" size="100%">ligand</style></keyword>,<keyword><style face="normal" font="default" size="100%">surfactant</style></keyword>,<keyword><style face="normal" font="default" size="100%">surfactant protein B</style></keyword></keywords></record><record><database name="EndNote.enl" path="c:\EndNote.enl">EndNote.enl</database><source-app name="EndNote" version="16.0">EndNote</source-app><rec-number>19</rec-number><foreign-keys><key app="EN" db-id="s55prpsswfsepue0xz25pxai2p909xtzszzv">undefined</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Verhein K.C.</style></author>,<author><style face="normal" font="default" size="100%">Burkholder A.</style></author>,<author><style face="normal" font="default" size="100%">Nichols J.L.</style></author>,<author><style face="normal" font="default" size="100%">McCaw Z.</style></author>,<author><style face="normal" font="default" size="100%">Marzec J.</style></author>,<author><style face="normal" font="default" size="100%">Panduri V.</style></author>,<author><style face="normal" font="default" size="100%">Gladwell W.</style></author>,<author><style face="normal" font="default" size="100%">Reeves N.</style></author>,<author><style face="normal" font="default" size="100%">Malphurs J.</style></author>,<author><style face="normal" font="default" size="100%">Solomon G.</style></author>,<author><style face="normal" font="default" size="100%">Wiltshire T.</style></author>,<author><style face="normal" font="default" size="100%">Fargo D.</style></author>,<author><style face="normal" font="default" size="100%">Bell D.</style></author>,<author><style face="normal" font="default" size="100%">Van Houten B.</style></author>,<author><style face="normal" font="default" size="100%">Kleeberger S.R.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Inter-strain variation in mouse mitochondrial genome and effects of oxidative stress</style></title><secondary-title><style face="normal" font="default" size="100%">FASEB Journal</style></secondary-title></titles><abstract><style face="normal" font="default" size="100%">Reactive oxygen species contribute to the pathogenesis of many acute and chronic pulmonary disorders, including bronchopulmonary dysplasia (BPD), a respiratory condition affecting preterm infants. BPD treatment often involves respiratory support with high O2, and oxidative stress is an adverse effect associated with vascular damage and impaired lung development and function in a subset of infants. Genetic polymorphisms in a few candidate genes have been associated with BPD susceptibility, however the genetic basis of differential susceptibility remains poorly understood. Understanding the role of genetics is critical to improving treatment strategies and reducing oxidant injury in developing lungs. We developed a neonatal mouse model to mimic many features of BPD, and utilized genome-wide association (GWA) mapping of quantitative phenotypes to identify susceptibility genes for neonatal hyperoxic lung injury. One day after birth, neonatal mice from 29 inbred strains were exposed for 72 hr to normoxia (room air, 20% O2) or hyperoxia (&gt;95% O2). Hyperoxia induced phenotypes (inflammatory cells/histopathology) that are similar to BPD when compared to normal postnatal lung development in normoxia. We also measured hyperoxia-induced lesions in nuclear (nuc) and mitochondrial (mt) DNA, and mitochondrial copy number from lung homogenates. Significant inter-strain variation was found for mtDNA and nucDNA lesions after normoxia and hyperoxia. GWA mapping identified significant quantitative trait loci for mtDNA lesions, nucDNA lesions, and mitochondrial copy number after normoxia and for hyperoxia. We ultra-deep sequenced neonatal lung mtDNA from mice exposed to normoxia and hyperoxia and found 385 sequence variations in wild-derived PWD/PhJ inbred mice compared to reference C57BL/6J mice. Higher variation frequency (1/32 bases) was found in the D-loop region compared to the rest of the mitochondrial genome (1/42 bases). There was also more heteroplasmy in PWD/PhJ mice compared to C57BL/6J. We found five haplotype groups among 27 strains that were sequenced, with classical inbred strains in haplotype 1, NZB and NZO mice in haplotype 2, and PWD/PhJ and PWK/PhJ mice in haplotype 3. Wild derived strains had more variation than classical inbred strains. We conclude that exposure to low (20%) and high (&gt;95%) concentrations of oxygen early in life cause lesions in mouse lung mtDNA and nucDNA that are strain dependent. Ultra-deep sequencing identified mtDNA sequence variation and differences in heteroplasmy and indels across inbred mouse strains that associate with disease phenotypes. Through these combined approaches, we have identified novel candidate susceptibility genes that may improve our understanding of neonatal lung injury and development.</style></abstract><accession-num><style face="normal" font="default" size="100%">72323698</style></accession-num><auth-address><style face="normal" font="default" size="100%">K.C. Verhein, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC, United States</style></auth-address><remote-database-name><style face="normal" font="default" size="100%">Embase</style></remote-database-name><isbn><style face="normal" font="default" size="100%">1530-6860</style></isbn><language><style face="normal" font="default" size="100%">English</style></language><number><style face="normal" font="default" size="100%">Meeting Abstracts
SP  -</style></number><volume><style face="normal" font="default" size="100%">30</style></volume><dates><pub-dates><date><style face="normal" font="default" size="100%">2016//</style></date></pub-dates></dates><urls><related-urls><url><style face="normal" font="default" size="100%">http://www.fasebj.org/content/30/1_Supplement/982.3.abstract?sid=5d28fc5d-fc3c-4012-b074-c612d173744b</style></url>,<url><style face="normal" font="default" size="100%">http://ovidsp.ovid.com/ovidweb.cgi?T=JS&amp;PAGE=reference&amp;D=emed17&amp;NEWS=N&amp;AN=72323698</style></url></related-urls></urls><keywords><keyword><style face="normal" font="default" size="100%">*mitochondrial genome</style></keyword>,<keyword><style face="normal" font="default" size="100%">*oxidative stress</style></keyword>,<keyword><style face="normal" font="default" size="100%">*mouse</style></keyword>,<keyword><style face="normal" font="default" size="100%">hyperoxia</style></keyword>,<keyword><style face="normal" font="default" size="100%">haplotype</style></keyword>,<keyword><style face="normal" font="default" size="100%">inbred strain</style></keyword>,<keyword><style face="normal" font="default" size="100%">phenotype</style></keyword>,<keyword><style face="normal" font="default" size="100%">gene</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung injury</style></keyword>,<keyword><style face="normal" font="default" size="100%">infant</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung development</style></keyword>,<keyword><style face="normal" font="default" size="100%">heteroplasmy</style></keyword>,<keyword><style face="normal" font="default" size="100%">inbred mouse strain</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung dysplasia</style></keyword>,<keyword><style face="normal" font="default" size="100%">human</style></keyword>,<keyword><style face="normal" font="default" size="100%">indel mutation</style></keyword>,<keyword><style face="normal" font="default" size="100%">genetic polymorphism</style></keyword>,<keyword><style face="normal" font="default" size="100%">genetics</style></keyword>,<keyword><style face="normal" font="default" size="100%">injury</style></keyword>,<keyword><style face="normal" font="default" size="100%">quantitative trait locus</style></keyword>,<keyword><style face="normal" font="default" size="100%">blood vessel injury</style></keyword>,<keyword><style face="normal" font="default" size="100%">ambient air</style></keyword>,<keyword><style face="normal" font="default" size="100%">adverse drug reaction</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung disease</style></keyword>,<keyword><style face="normal" font="default" size="100%">assisted ventilation</style></keyword>,<keyword><style face="normal" font="default" size="100%">genome</style></keyword>,<keyword><style face="normal" font="default" size="100%">lung homogenate</style></keyword>,<keyword><style face="normal" font="default" size="100%">mouse model</style></keyword>,<keyword><style face="normal" font="default" size="100%">prematurity</style></keyword>,<keyword><style face="normal" font="default" size="100%">exposure</style></keyword>,<keyword><style face="normal" font="default" size="100%">pathogenesis</style></keyword>,<keyword><style face="normal" font="default" size="100%">mitochondrial DNA</style></keyword>,<keyword><style face="normal" font="default" size="100%">oxidizing agent</style></keyword>,<keyword><style face="normal" font="default" size="100%">oxygen</style></keyword>,<keyword><style face="normal" font="default" size="100%">reactive oxygen metabolite</style></keyword>,<keyword><style face="normal" font="default" size="100%">DNA</style></keyword></keywords></record></records></xml>